Natera
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
NTRA Key Statistics
NTRA News
Natera Inc. ((NTRA)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlo...
Natera Inc. ((NTRA)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlo...
Natera Inc. ((NTRA)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlo...
Analyst ratings
90%
of 21 ratingsMore NTRA News
Natera recently reported results from the phase 3 IMvigor011 trial, showing its Signatera test can enhance treatment selection and improve both disease-free and...
Investors in Natera Inc (Symbol: NTRA) saw new options become available today, for the November 2026 expiration. One of the key data points that goes into the p...
BNP Paribas Exane analyst Navann Ty upgraded Natera (NTRA) to Neutral from Underperform with a $172 price target Published first on TheFly – the ultimate sourc...
Over the past month, Natera (NTRA) shares have advanced 17%, fueled by steady annual revenue growth and sharply improving net income trends. Investors are eyein...
In a report released yesterday, Kyle Mikson CFA from Canaccord Genuity maintained a Buy rating on Natera, with a price target of $200.00. Elevate Your Investing...
Mark Massaro, an analyst from BTIG, reiterated the Buy rating on Natera. The associated price target was raised to $210.00. Elevate Your Investing Strategy: Tak...
BTIG analyst Mark Massaro raised the firm’s price target on Natera (NTRA) to $2 10 from $200 and keeps a Buy rating on the shares. The firm is positive on Nater...